Do you want to read an article? Please log in or register.
Pleuropulmonary Involvement in Erdheim-Chester Disease: Analysis of 24 Biopsy-Proven Cases
Further Publications
Related content
Interstitial Lung DiseasePneumonia
High-Resolution CT Findings in Interstitial Lung Disease Associated with Connective Tissue Diseases: Differentiating Patterns for Clinical Practice-A Systematic Review with Meta-Analysis
J Clin Med
Drimus JC, Duma RC, Trăilă D, Mogoșan CD, Manolescu DL, Fira-Mladinescu O
doi: 10.3390/jcm14176164
Interstitial Lung Disease
The impact of interstitial lung disease in patients with acid sphingomyelinase deficiency (ASMD) - A case series
Respir Med Case Rep
Costa I Colomer J, Garcia-Moyano M, Maiz L, Perez-Tarazona S, Ruiz de Valbuena M, Ceberio L, Correcher P, Juliá-Palacios N, Morales M, Pérez-Yagüe G, Villarrubia J, Pérez-Rojo R
doi: 10.1016/j.rmcr.2025.102202
Further Publications
Nodular pulmonary amyloidosis presenting as a localized manifestation of lymphoproliferative disease: A three-case series
Respir Med Case Rep
Chandna S, Raval R, Rangwala T, Mehta AC
doi: 10.1016/j.rmcr.2025.102353
COMMENTED
Interstitial Lung Disease
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. Developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM
doi: 10.1183/13993003.02533-2024
COMMENTED
COPD
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB
doi: 10.1016/S2213-2600(24)00409-0
COMMENTED
Interstitial Lung Disease
Inhalational exposures associated with risk of interstitial lung disease: a systematic review and meta-analysis
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax
Lee CT, Gandhi SA, Elmrayed S, Barnes H, Lorenzetti D, Salisbury ML, Stewart ID, Barber C, Peters CE, Feary J, Johannson KA
doi: 10.1136/thorax-2024-222306
COPD
Non-Pharmacological Interventions for Fatigue in Patients with Chronic Obstructive Pulmonary Disease: a Systematic Review and Network Meta-Analysis
Respir Med
Zhang X, Xue J, Chang Y, Zhang R, Zhao J, Li X, Lu H, Jiang X, Yu F, Yang P
doi: 10.1016/j.rmed.2025.108409
RECOMMENDED
COPD
Thyroid hormones in persons with chronic obstructive pulmonary disease: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Vázquez PF, Díez-Manglano J
doi: 10.1016/j.rmed.2025.108103
COPD
Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial
Eur J Heart Fail
Butt JH, Jhund PS, Henderson AD, Claggett BL, Desai AS, Lam CSP, Mueller K, Scheerer MF, Viswanathan P, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV
doi: 10.1002/ejhf.3661